Get Full access to Top 1000 data, subscribe from only €29

Alkermes

Add to comparison

Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Financial Data

31st Dec 18 Source: CRO
- €662.9 million turnover
- -€145.7 million profit
- 361 employees
- Auditor: PwC
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 17 Source: Company
- €541.4 million turnover
- -€146.6 million profit
- 2,000 employees
6 more years available »